Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-24-027693
Filing Date
2024-08-23
Accepted
2024-08-23 17:33:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A opk20240821c_sc13da.htm SC 13D/A 83070
  Complete submission text file 0001437749-24-027693.txt   85212
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filed by) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 LUDLOW STREET NORTH TOWER, 8TH FLOOR STAMFORD CT 06902
Business Address 333 LUDLOW STREET NORTH TOWER, 8TH FLOOR STAMFORD CT 06902 617 780 8742
GeneDx Holdings Corp. (Subject) CIK: 0001818331 (see all company filings)

EIN.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91664 | Film No.: 241237332
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)